SCHEMBL4902449

SCHEMBL4902449

CCN(Sc1nc(-c2ccccc2)cs1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
TP53 P04637 1/20 0.44
MCL1 Q07820 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TDP1 Q9NUW8 1/20 0.42
HPGD P15428 1/20 0.41
GFER P55789 1/20 0.40
PHGDH O43175 3/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
RORC P51449 1/20 0.38
LMNA P02545 1/20 0.38
PTPRB P23467 2/20 0.37
PTPRF P10586 1/20 0.37
PTPN2 P17706 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906794 0.91 NPC1 (0.42) L3MBTL1NPC1RAB9AMEN1KMT2A
SCHEMBL4901805 0.90 TSHR (0.44) TSHRTP53MCL1L3MBTL1NPC1
SCHEMBL4906202 0.84 RAB9A (0.44) TSHRL3MBTL1NPC1RAB9AMEN1
SCHEMBL4905500 0.83 NPC1 (0.41) TSHRTP53MCL1L3MBTL1NPC1
SCHEMBL4905953 0.82 ALDH1A1 (0.46) TSHRTP53NPC1RAB9AMEN1
SCHEMBL4902435 0.79 TSHR (0.49) TSHRTP53MCL1L3MBTL1NPC1
SCHEMBL4906163 0.79 KMT2A (0.44) TSHRNPC1RAB9AMEN1KMT2A
SCHEMBL4902656 0.76 LMNA (0.44) TSHRNPC1RAB9AMEN1KMT2A
SCHEMBL5930457 0.76 PPARA (0.46) TSHRL3MBTL1SMN1; SMN2ALDH1A1LMNA
SCHEMBL4894507 0.74 ALDH1A1 (0.48) TSHRTP53L3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TSHR 412/4885TP53 3260/4885MCL1 4160/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TSHR 400/4885TP53 3421/4885MCL1 4319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TSHR 400/4885TP53 3421/4885MCL1 4319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.